Publications by authors named "A Davide Mirabella"
The pursuit of environmentally friendly solvents has become an essential research topic in sustainable chemistry and nanomaterial science. With the need to substitute toxic solvents in nanofabrication processes becoming more pressing, the search for alternative solvents has taken on a crucial role in this field. Additionally, the use of toxic, non-economical organic solvents, such as N-methyl-2 pyrrolidone and dimethylformamide, is not suitable for all biomedical applications, even though these solvents are often considered as the best exfoliating agents for nanomaterial fabrication.
View Article and Find Full Text PDFBackground And Objectives: Human trafficking is a significant problem in which healthcare workers are in a unique position to intervene. This study sought to determine the self-reported knowledge levels of healthcare providers most likely to come in direct contact with victims of human trafficking.
Methods: An anonymous survey assessing self-reported knowledge of human trafficking was developed and distributed online.
Article Synopsis
- * This international trial includes a randomized controlled aspect (REAPPEAR-T) and a cohort study (REAPPEAR-C), focusing on changes in alcohol use and smoking among hospitalized daily smokers with alcohol-related acute pancreatitis.
- * Participants will be monitored through questionnaires and regular health assessments, with the primary goal being to measure the recurrence rate of pancreatitis and overall mortality within two years, while also evaluating the program's cost-effectiveness.
Problem Statement: This study assesses the effect of a nurse-designed SMART educational intervention on goal attainment, patient empowerment, and satisfaction.
Design: A mixed-methods study design was used.
Data Sources: 68 adults with cancer were recruited from an oncology research center and randomized to the immediate or waitlist control group.
Purpose: New immuno-oncology therapies targeting programmed cell death receptor 1 (PD-1) have improved patient outcomes in a broad range of cancers. The objective of this analysis was to evaluate the PK, pharmacodynamics (PDy), and safety of dostarlimab monotherapy in adult patients with previously-treated advanced solid tumors who participated in parts 1 and 2A of the phase 1 GARNET study.
Methods: Part 1 featured a 3 + 3 weight-based dose-escalation study, in which 21 patients received dostarlimab 1, 3, or 10 mg/kg intravenously every 2 weeks.